
Amelparib
CAS No. 1227156-72-0
Amelparib( JPI-289 | JPI289 )
Catalog No. M10874 CAS No. 1227156-72-0
Amelparib (JPI-289, JPI289) is a novel potent, water soluble PARP-1 inhibitor with IC50 of 18.5 nM, inhibits cellular PAR formation with IC50 of 10.7 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 1143 | Get Quote |
![]() ![]() |
50MG | 2322 | Get Quote |
![]() ![]() |
100MG | 3060 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAmelparib
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmelparib (JPI-289, JPI289) is a novel potent, water soluble PARP-1 inhibitor with IC50 of 18.5 nM, inhibits cellular PAR formation with IC50 of 10.7 nM.
-
DescriptionAmelparib (JPI-289, JPI289) is a novel potent, water soluble PARP-1 inhibitor with IC50 of 18.5 nM, inhibits cellular PAR formation with IC50 of 10.7 nM; does not affect cell viability up to 1 mM in rat cortical neuronal cells; attenuates PARP activity restores ATP and NAD+ levels in oxygen glucose deprived (OGD) rat cortical neurons, reduces apoptosis-associated molecules such as apoptosis inducing factor (AIF), cytochrome C and cleaved caspase-3 in the OGD model; JPI-289 is a potential neuroprotective agent which could be useful as a treatment for acute ischaemic stroke.Stroke Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsJPI-289 | JPI289
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP
-
Research AreaNeurological Disease
-
IndicationStroke
Chemical Information
-
CAS Number1227156-72-0
-
Formula Weight343.427
-
Molecular FormulaC19H25N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (291.19 mM)
-
SMILESO=C1C2=C(NCCC2)C3=C(OCC)C=C(CN4CCOCC4)C=C3N1
-
Chemical Name10-ethoxy-8-[(morpholin-4-yl)methyl]-2,3,4,6-tetrahydrobenzo[h][1,6]naphthyridin-5(1H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim Y, et al. Clin Exp Pharmacol Physiol. 2017 Jun;44(6):671-679.
2. Kim Y, et al. Mol Neurobiol. 2018 Jan 30. doi: 10.1007/s12035-018-0910-6.
molnova catalog



related products
-
BYK204165
BYK204165 is a potent PARP inhibitor?(PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).
-
PARP1/2/TNKS1/2-IN-1
PARP1/2/TNKS1/2-IN-1 is a multi-target inhibitor of PARP-1, PARP-2, TNKS1, and TNKS2, with potential anti-tumor activity that induces apoptosis.
-
Gemcabene calcium
Gemcabene (PD-72953, PD72953) is a first-in-class lipid-lowering agent and activator of PARP.